- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
February 10, 2020
Neoadjuvant vs adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis.
February 10, 2020
Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?
February 10, 2020
Atypical Early Recurrence after Robot-Assisted Radical Cystectomy: Port-Site Metastasis.
February 7, 2020
Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection.
February 7, 2020
Early Postoperative Morbidity of Robotic Versus Open Radical Cystectomy in Obese Patients.
February 7, 2020
Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.
February 6, 2020
BCG Immunotherapy Versus Radical Cystectomy in Intermediate or High-Risk Non-Muscle Invasive Bladder Cancer Patients - Expert Commentary
February 5, 2020
Clinical and pathological characteristics of bladder cancer in post brachytherapy patients.
February 5, 2020
PD-L1 assessment in urothelial carcinoma: a practical approach.
February 5, 2020
Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials.
February 5, 2020
The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing.
February 4, 2020
Exploring patients' experience and perception of being diagnosed with bladder cancer: A mixed methods approach.
February 4, 2020
A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis.
February 4, 2020
Intravesical BCG Versus Radical Cystectomy for High-Risk NMIBC with Histologic Variants - Expert Commentary
February 3, 2020